NIR-laser-controlled drug release from DOX/IR-780-loaded temperature-sensitive-liposomes for chemo-photothermal synergistic tumor therapy

Theranostics

Volumn 6, Issue 13, 2016, Pages 2337-2351

  Yan, Fei ^a,c   Duan, Wanlu ^b   Li, Yekuo ^b   Wu, Hao ^c   Zhou, Yuli ^d   Pan, Min ^a   Liu, Hongmei ^c   Liu, Xin ^a   Zheng, Hairong ^a,c  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^d SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

Breast tumors; Doxorubicin; IR 780; Photothermal therapy; Temperature sensitive liposome

Indexed keywords

DOXORUBICIN; IR 780; LIPOSOME; NANOPARTICLE; PHOTOSENSITIZING AGENT; TEMPERATURE SENSITIVE LIPOSOME; UNCLASSIFIED DRUG; 2-(2-(2-CHLORO-3-((1,3-DIHYDRO-3,3-DIMETHYL-1-PROPYL-2H-INDOL-2-YLIDENE)ETHYLIDENE)-1-CYCLOHEXEN-1-YL)ETHENYL)-3,3-DIMETHYL-1-PROPYLINDOLIUM; ANTINEOPLASTIC AGENT; DRUG CARRIER; INDOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; FEMALE; HISTOPATHOLOGY; IRRADIATION; LASER; LIPID BILAYER; MOUSE; NEAR INFRARED LASER; NONHUMAN; PHOTOTHERMAL THERAPY; ANIMAL; BREAST NEOPLASMS; DISEASE MODEL; DRUG RELEASE; DRUG THERAPY; HUMAN; INFRARED RADIATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; TREATMENT OUTCOME; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG CARRIERS; DRUG LIBERATION; DRUG THERAPY; HETEROGRAFTS; HUMANS; INDOLES; INFRARED RAYS; LASERS; LIPOSOMES; MICE; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 84999748038     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.14937     Document Type: Article

References (50)

1. Shibu ES, Hamada M, Murase N, Biju V. Nanomaterials formulations for photothermal and photodynamic therapy of cancer. J Photoch Photobio C. 2013;15: 53-72.
2. Wang Y, Xiao Y, Tang R. Spindle-like polypyrrole hollow nanocapsules as multifunctional platforms for highly effective chemo-photothermal combination therapy of cancer cells in vivo. Chemistry. 2014;20: 11826-34.
3. You J, Zhang R, Xiong C, et al. Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Can Res. 2012; 72: 4777-86.
4. Poulose AC, Veeranarayanan S, Mohamed MS, et al. Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents. Nanoscale. 2015;7: 8378-88.
5. Zhang Z, Wang J, Chen C. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater. 2013; 25: 3869-80.
6. Zhang W, Guo Z, Huang D, et al. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011; 32: 8555-61.
7. Peralta DV, Heidari Z, Dash S, et al. Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells. ACS Appl Mater Inter. 2015; 7: 7101-11.
8. Tao Y, Ju E, Liu Z, et al. Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy. Biomaterials. 2014; 35: 6646-56.
9. Kim H, Kang J, Chang JH. Thermal therapeutic method for selective treatment of deep-lying tissue by combining laser and high-intensity focused ultrasound energy. Opt Lett. 2014; 39: 2806-9.
10. Wang C, Xu L, Liang C, et al. Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv Mater. 2014; 26: 8154-62.
11. Zheng M, Yue C, Ma Y, et al. Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano. 2013;7: 2056-67.
12. Liao J, Li W, Peng J, et al. Combined cancer photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes. Theranostics. 2015; 5: 345-56.
13. Kim HJ, Lee SM, Park KH, et al. Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis. Biomaterials. 2015; 61: 95-102.
14. Konig K. Multiphoton microscopy in life sciences. J Microsc. 2000; 200: 83-104.
15. Hauck TS, Jennings TL, Yatsenko T, et al. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv Mater. 2008; 20: 3832-8.
16. Wang Y, Black KC, Luehmann H, et al. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano. 2013; 7: 2068-77.
17. Park H, Yang J, Lee J, et al. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS nano. 2009; 3: 2919-26.
18. Zhou M, Li J, Liang S, et al. CuS Nanodots with ultrahigh efficient renal clearance for positron emission tomography imaging and image-guided photothermal therapy. ACS Nano. 2015; 9:7085-96.
19. Monem AS, Elbialy N, Mohamed N. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy. Int J Pharm. 2014; 470: 1-7.
20. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014; 14: 199-208.
21. Ganta S, Devalapally H, Shahiwala A, et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008; 126: 187-204.
22. Lopez-Noriega A, Ruiz-Hernandez E, Quinlan E, et al. Thermally triggered release of a pro-osteogenic peptide from a functionalized collagen-based scaffold using thermosensitive liposomes. J Control Release. 2014; 187: 158-66.
23. May JP, Li SD. Hyperthermia-induced drug targeting. Expert Opin Drug Deliv. 2013; 10: 511-27.
24. Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliver Rev. 2001; 53: 285-305.
25. Shemesh CS, Moshkelani D, Zhang H. Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer. Pharm Res. 2015; 32:1604-14.
26. Guo F, Yu M, Wang J, et al. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. ACS Applied Materials & Interfaces. 2015; 7: 20556-67.
27. de Smet M, Langereis S, van den Bosch S. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release. 2010; 143: 120-7.
28. Yue C, Liu P, Zheng M, et al. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials. 2013; 34: 6853-61.
29. Park SM, Kim MS, Park SJ, et al. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). J Control Release. 2013; 170: 373-9.
30. Kim MS, Lee DW, Park K, et al. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Colloid Surface B. 2014; 116: 17-25.
31. Jiang C, Cheng H, Yuan A, et al. Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy. Acta Biomater. 2015;14: 61-9.
32. Al-Jamal WT, Al-Ahmady ZS, Kostarelos K. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia. Biomaterials. 2012; 33: 4608-17.
33. Tagami T, Ernsting MJ, Li SD. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release. 2011; 152: 303-9.
34. Banno B, Ickenstein LM, Chiu GN, et al. The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. J pharm sci. 2010; 99: 2295-308.
35. Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci. 1980; 335: 180-205.
36. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005; 127: 208-23.
37. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliver Rev. 2001; 53: 321-39.
38. Deng Z, Zhen Z, Hu X, et al. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials. 2011; 32: 4976-86.
39. Yatvin MB, Weinstein JN, Dennis WH, et al. Design of liposomes for enhanced local release of drugs by hyperthermia. Science. 1978; 202: 1290-3.
40. Shanmugam V, Selvakumar S, Yeh CS. Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev. 2014; 43: 6254-87.
41. Kim H, Jeong SM, Park JW. Electrical switching between vesicles and micelles via redox-responsive self-assembly of amphiphilic rod-coils. J Am Chem Soc. 2011; 133: 5206-9.
42. Chen KJ, Liang HF, Chen HL, et al. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. ACS nano. 2013; 7: 438-46.
43. Tang Y, Lei T, Manchanda R, et al. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study. Pharm Res. 2010; 27: 2242-53.
44. Wang Y, Liu T, Zhang E, et al. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials. 2014; 35: 4116-24.
45. Lagadinou ED, Sach A, Callahan K, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12: 329-41.
46. Peng CL, Shih YH, Lee PC et al. Multimodal image-guided photothermal therapy mediated by 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano. 2011; 5: 5594-607.
47. Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003; 100: 13549-54.
48. Anyarambhatla GR, Needham D. Enhancement of the Phase Transition Permeability of DPPC Liposomes by Incorporation of MPPC: A New Temperature-Sensitive Liposome for use with Mild Hyperthermia. J Liposome Res. 1999; 9: 491-506.
49. Wang K, Zhang X, Liu Y, et al. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates. Biomaterials. 2014; 35: 8735-47.
50. Al-Jamal KT, Al-Jamal WT, Wang JTW, et al. Cationic poly-l-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo. ACS nano. 2013; 7: 1905-17.